blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3383394

EP3383394 - NOVEL ALPHA-HYDROXY CARBOXYLIC ACID AND DERIVATIVES AND OTHER GRAS- BASED PRODRUGS OF OXYMORPHONE AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.12.2020
Database last updated on 12.07.2024
FormerExamination is in progress
Status updated on  22.11.2019
FormerRequest for examination was made
Status updated on  07.09.2018
FormerThe international publication has been made
Status updated on  15.06.2017
Most recent event   Tooltip25.12.2020Application deemed to be withdrawnpublished on 27.01.2021  [2021/04]
Applicant(s)For all designated states
Thottathil, John K.
28630 Skycrest Dr.
Mundelein, Illinois 60060 / US
[2018/41]
Inventor(s)01 / see applicant
...
 [2018/41]
Representative(s)FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39 / IE
[N/P]
Former [2018/41]FRKelly
27 Clyde Road
Dublin D04 F838 / IE
Application number, filing date16871311.328.11.2016
[2018/41]
WO2016US63836
Priority number, dateUS20151495614301.12.2015         Original published format: US201514956143
[2018/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017095734
Date:08.06.2017
Language:EN
[2017/23]
Type: A1 Application with search report 
No.:EP3383394
Date:10.10.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 08.06.2017 takes the place of the publication of the European patent application.
[2018/41]
Search report(s)International search report - published on:US08.06.2017
(Supplementary) European search report - dispatched on:EP19.06.2019
ClassificationIPC:A61K31/485, A61P25/36, A61K9/00, A61K47/54
[2019/29]
CPC:
A61K31/485 (EP,US); A61K47/542 (EP,US); A61K47/543 (US);
A61K9/0053 (EP,US); A61P25/36 (EP,US)
Former IPC [2018/41]A61K31/485, A61P25/36, C07D489/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/41]
TitleGerman:NEUARTIGE ALPHA-HYDROXY-CARBONSÄURE UND DERIVATE UND ANDERE GRAS-BASIERTE PRODRUGS VON OXYMORPHON SOWIE VERWENDUNGEN DAVON[2018/41]
English:NOVEL ALPHA-HYDROXY CARBOXYLIC ACID AND DERIVATIVES AND OTHER GRAS- BASED PRODRUGS OF OXYMORPHONE AND USES THEREOF[2018/41]
French:NOUVEL ACIDE ALPHA-HYDROXY CARBOXYLIQUE ET DÉRIVÉS ET AUTRES PROMÉDICAMENTS D'OXYMORPHONE À BASE DE GRAS ET LEURS UTILISATIONS[2018/41]
Entry into regional phase25.10.2017National basic fee paid 
25.10.2017Search fee paid 
25.10.2017Designation fee(s) paid 
25.10.2017Examination fee paid 
Examination procedure25.10.2017Examination requested  [2018/41]
25.10.2017Date on which the examining division has become responsible
29.10.2019Amendment by applicant (claims and/or description)
26.11.2019Despatch of a communication from the examining division (Time limit: M02)
21.01.2020Reply to a communication from the examining division
25.03.2020Despatch of a communication from the examining division (Time limit: M02)
02.06.2020Reply to a communication from the examining division
17.06.2020Despatch of a communication from the examining division (Time limit: M02)
28.08.2020Application deemed to be withdrawn, date of legal effect  [2021/04]
18.09.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/04]
Fees paidRenewal fee
14.11.2018Renewal fee patent year 03
14.11.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2004082620  (CONTROLLED CHEMICALS INC [US]) [X] 1,14,15 * table I left col. last compd * * compounds 7,8 *;
 [X]WO2007120648  (NEW RIVER PHARMACEUTICALS INC [US], et al) [X] 2-4,14,15* example 13 *;
 [X]US2010286186  (FRANKLIN RICHARD [GB], et al) [X] 1,5,6,14,15 * tables 4 entries 2, 7 *;
 [E]WO2017091827  (THOTTATHIL JOHN K [US]) [E] 1-15 * claims 1-21 * * compounds Formulae 1-91 *
International search[XY]US2010286186  (FRANKLIN RICHARD [GB], et al) [X] 1-4, 5/1-2, 7/5/1-2, 8/5/1-2, 12/5/1-2, 17/1-2, 18/17/1-2, 19/17/1-2, 20/1-2, 21/1-2 * ; paragraphs [0016]. [0037], [0040], [0043], [0063]-[0065], [0088]-[0089], [0435]-[0451], [0480], [0668], [0686], [0688] * [Y] 9/5/1-2, 10/9/5/1-2, 13/5/1-2, 14/13/5/1-2, 15-16;
 [Y]US2005075361  (WANG JHI-JOUNG [TW]) [Y] 9/5/1-2, 10/9/5/1-2, 13/5/1-2, 14/13/5/1-2 * ; paragraphs [0008], [0018], [0062], [0068]-[0070] *;
 [Y]US4673679  (AUNGST BRUCE J [US], et al) [Y] 15-16 * ; column 1, lines 8-10; column 2, lines 56-68; column 3, line 20 *;
 [A]US2014200235  (RIGGS-SAUTHIER JENNIFER [US], et al) [A] 6/5/1-2, 11/5/1-2 * ; paragraphs [0110]-[0113] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.